RPG Life Sciences inks pact to acquire seven prescription brands of Sun Pharma

28 Jul 2016 Evaluate

RPG Life Sciences of the RPG Group has signed an agreement to acquire seven prescription brands from Sun Pharmaceuticals Industries for Rs 41 crore. The agreement is in line with company’s strategy to focus on formulations business. The acquired brands are primarily in respiratory and urology segments.

In addition to this, three products will complement the company’s existing range. The deal is subject to approval by the Competition Commission of India (CCI).

RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.

 

RPG Life Sciences Share Price

1489.90 35.05 (2.41%)
16-May-2024 15:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1535.35
Dr. Reddys Lab 5869.15
Cipla 1421.55
Zydus Lifesciences 1009.15
Lupin 1663.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.